151 related articles for article (PubMed ID: 7382975)
1. Protocol for management of unsuccessful pregnancy.
Hodgson JE; Ditmanson GM
Minn Med; 1980 Feb; 63(2):134-8. PubMed ID: 7382975
[TBL] [Abstract][Full Text] [Related]
2. Management of missed abortion, intrauterine death and hydatidiform mole using prostaglandin E2.
Murray CP; Clinch J
Ir Med J; 1975 Mar; 68(6):133-5. PubMed ID: 1120656
[TBL] [Abstract][Full Text] [Related]
3. Intrauterine (extraamniotic) prostaglandins in the management of unsuccessful pregnancy.
Calder AA; Mackenzie IZ; Embrey MP
J Reprod Med; 1976 May; 16(5):271-5. PubMed ID: 933106
[TBL] [Abstract][Full Text] [Related]
4. Management of intrauterine fetal demise and missed abortion using prostaglandin E2 vaginal suppositories.
Southern EM; Gutknecht GD
Obstet Gynecol; 1976 May; 47(5):602-6. PubMed ID: 1264407
[TBL] [Abstract][Full Text] [Related]
5. Missed abortion, hydatidiform mole and intra-uterine fetal death treated with 15-methyl-prostaglandin F 2-alpha.
Boes EG
S Afr Med J; 1980 Nov; 58(22):878-80. PubMed ID: 7434122
[TBL] [Abstract][Full Text] [Related]
6. Extra-amniotic prostaglandin E2 and intravenous oxytocin in termination of mid-trimester pregnancy and the management of missed abortion and hydatiform mole.
Arshat H
Med J Malaysia; 1977 Mar; 31(3):220-5. PubMed ID: 904515
[TBL] [Abstract][Full Text] [Related]
7. The use of prostaglandin E2 vaginal suppository in missed abortion, intrauterine death and hydatidiform mole.
Takagi LR; Gulling EA; O'Leary JA
J Med Assoc Ga; 1978 Aug; 67(8):644-5. PubMed ID: 574529
[No Abstract] [Full Text] [Related]
8. [Drug treatment of retained abortion, intrauterine death of the fetus and of vesicular mole with 15-ME-PGF2alpha].
Granese D; Pullè C; Carroccio G; Scurria L; Benedetto V; Silva A
Minerva Ginecol; 1982 Jun; 34(6):467-74. PubMed ID: 7133533
[No Abstract] [Full Text] [Related]
9. Extraamniotic prostaglandin F2 alpha for intrauterine death and fetal abnormality.
Luengo J; Keirse MJ; Bennebroek Gravenhorst J
Eur J Obstet Gynecol Reprod Biol; 1977; 7(5):325-9. PubMed ID: 299460
[TBL] [Abstract][Full Text] [Related]
10. Induction of abortion and labor by extraamniotic isotonic saline, with or without addition of oxytocin, in cases of missed abortion, missed labor and antepartum fetal death.
Blum M; Goldman JA
Int Surg; 1977 Feb; 62(2):95-6. PubMed ID: 844975
[TBL] [Abstract][Full Text] [Related]
11. [Induction of labor in missed abortion, fetal death and vesicular mole, using PGF2 alpha by extra-amniotic intracavitary administration].
Paladini A; Di Lieto A; Martinelli P; De Placido G; Di Meglio A
Minerva Ginecol; 1977 Dec; 29(12):931-8. PubMed ID: 609402
[TBL] [Abstract][Full Text] [Related]
12. Use of prostaglandin E2 vaginal suppositories in intrauterine fetal death and missed abortion.
Bailey CD; Newman C; Ellinas SP; Anderson GG
Obstet Gynecol; 1975 Jan; 45(1):110-3. PubMed ID: 1110809
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intra-amniotic (15S)-15-methyl-PGF2 alpha and intravaginal prostaglandin E2 for second-trimester uterine evacuation.
Perry KG; Roberts WE; Martin RW; Magann EF; Sullivan DL; Morrison JC
J Perinatol; 1998; 18(1):24-7. PubMed ID: 9527940
[TBL] [Abstract][Full Text] [Related]
14. [Prostaglandins for the termination of pathological pregnancies in the 2d trimester].
Gruber W
Wien Klin Wochenschr; 1982 Oct; 94(20):558-60. PubMed ID: 6963074
[TBL] [Abstract][Full Text] [Related]
15. [Administration of 15-(S)-15-methyl prostaglandins F2 alpha in intrauterine fetal death, missed abortion and hydatidiform mole (author's transl)].
Husslein P; Reinold E
Wien Klin Wochenschr; 1979 Jun; 91(13):458-60. PubMed ID: 463045
[TBL] [Abstract][Full Text] [Related]
16. Termination of pregnancy in patients with missed abortion and intrauterine dead fetuses by a single intracervical application of prostaglandin E2 in viscous gel.
Ekman G; Forman A; Ulmsten U; Wingerup L
Zentralbl Gynakol; 1980; 102(4):219-22. PubMed ID: 7467962
[TBL] [Abstract][Full Text] [Related]
17. [Induction of internal abortion and vesicular mole with intramuscular administration of 15(S)15-methyl-prostaglandin F2alpha].
Nasi A; De Murtas M; Bianchi V; Mela S; Tomasi C; Silva A
Minerva Ginecol; 1982 Jun; 34(6):461-6. PubMed ID: 7133532
[No Abstract] [Full Text] [Related]
18. Midtrimester pregnancy termination for fetal malformations. Use of intravaginal prostaglandin E2.
Hagar DL; Valley MT; Rayburn WF; Carey JC
J Reprod Med; 1997 Aug; 42(8):497-500. PubMed ID: 9284011
[TBL] [Abstract][Full Text] [Related]
19. [Prostaglandin F2alpha as a method of choice for interruption of pregnancy (author's transl)].
Zahn V; Johannigmann J
Geburtshilfe Frauenheilkd; 1975 Mar; 35(3):203-10. PubMed ID: 1055706
[TBL] [Abstract][Full Text] [Related]
20. [Induction of internal abortion, of hydatidiform mole in the 2d and 3d trimesters of pregnancy, with a dead fetus, using transcervical intra-amniotic injection of PGF2 alpha].
Rizzuto E; D'Urso G
Minerva Ginecol; 1977 Oct; 29(10):775-800. PubMed ID: 593617
[No Abstract] [Full Text] [Related]
[Next] [New Search]
